Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
TMO · NYSE · United States · Measuring & Controlling Devices, Nec
In shortTHERMO FISHER SCIENTIFIC INC. is profitable, generates cash and carries moderate debt, with revenue growing (+3.9% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 17.4% | 75/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 15.0% | 80/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 13.0% | 65/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.7% | 51/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.89× | 91/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.74× | 70/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 3.33× | 19/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 5.46× | 38/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 4.01 | 75/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 14.1% | 76/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.94× | 80/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 10.8% | 71/100 |
| Operating margin volatility | 3.8% | 74/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -0.3% | 15/100 |
|---|---|---|
| EPS growth, 3-year average | 0.2% | 26/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 39,211 | 44,915 | 42,857 | 42,879 | 44,556 |
| Research & development | 1,406 | 1,471 | 1,337 | 1,390 | 1,397 |
| Selling, general & admin | 8,007 | 8,993 | 8,445 | 8,595 | 8,732 |
| Operating income | 10,028 | 8,393 | 6,859 | 7,337 | 7,746 |
| Interest expense | 536 | 726 | 1,375 | 1,390 | 1,419 |
| Pre-tax income | 8,841 | 7,835 | 6,298 | 7,037 | 7,308 |
| Income tax | 1,109 | 703 | 284 | 657 | 547 |
| Net income | 7,725 | 6,950 | 5,995 | 6,335 | 6,704 |
| Diluted EPS | $19.46 | $17.63 | $15.45 | $16.53 | $17.74 |
| Diluted shares (millions) | 397 | 394 | 388 | 383 | 378 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
4.01 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 27, 2026 · Data updated Jul 31, 2026